February 28, 2022
University of Cincinnati Research Focuses on Key Protein in Heart Failure
February 28, 2022 – Research from the University of Cincinnati is examining a protein that plays a key role in heart…
Read More
February 28, 2022
Study: Bilobalide Reduces Cardiac Damage in Myocardial Ischemia
February 28, 2022  – The normal functioning of human body requires a steady flow of energy. This energy in the form of…
Read More
image of a heart
February 28, 2022
Cardiovascular Disease Concerns Pump Sales of Cardiac Markers to $2.5 Billion
February 28, 2022 – Despite improvements in treatment and increased public awareness about prevention, cardiovascular…
Read More
Experts from the Smidt Heart Institute at Cedars-Sinai led the project, which resulted in an anthology of 14 scientific articles that review the past decade of research on women’s cardiovascular health.
February 28, 2022
A Decade of Women’s Heart Health, Reexamined
February 28, 2022 — A new collection of scientific articles published today shines a light on the differences between…
Read More
Lou Dell'Italia, M.D.
February 25, 2022
Two Elevated Biomarkers Distinguish Blacks with Resistant Hypertension
February 25, 2022 – University of Alabama at Birmingham researchers are calling for a wider study of racial differences…
Read More
TrapLiner Catheter
February 25, 2022
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures
February 25, 2022 – Teleflex Incorporated, a leading global provider of medical technologies, today announced that the…
Read More
Scoreflex Scoring Balloon
February 25, 2022
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex Scoring Balloon
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional…
Read More
artificial intelligence tool
February 25, 2022
New Artificial Intelligence Tool Detects Often Overlooked Heart Diseases
Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool…
Read More
CardioMEMS sensor
February 25, 2022
Abbott’s CardioMEMS HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded…
Read More
Jaimin Trivedi, University of Louisville Department of Cardiovascular and Thoracic Surgery
February 25, 2022
UofL Study Shows Improvement in Heart Transplant Access, Outcomes for Black Patients
February 25, 2022 – Researchers at the University of Louisville analyzed data for heart transplants from 1987 to 2019…
Read More
Intravascular Optical Coherence Tomography (IVOCT)
February 25, 2022
Dyad Medical Secures FDA Clearance For Cardiac Image Analysis Platform
February 25, 2022 – Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis…
Read More
February 25, 2022
Breakthrough Study Uses Genetic Testing to Evaluate Risk of Heart Disease
February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic…
Read More
The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
February 24, 2022
FDA Approves Empagliflozin for Reducing Risk of Heart Failure
February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of…
Read More
The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil lawsuit today to stop UnitedHealth Group Incorporated (United) from acquiring Change Healthcare Inc. (Change).
February 24, 2022
Justice Department Sues to Block UnitedHealth Group’s Acquisition of Change Healthcare
February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil…
Read More
We are at the precipice of a huge development in patient care, with the first smart hospital already announced last year in Southeast Asia. To keep pace, governments in the US and Europe need to increase investment in 5G networks, as these will be essential to meet the high network demands.
February 24, 2022
Significant Expansion of 5G Networks Could be the Catalyst Towards Smart Hospitals
February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you…
Read More
Scientists have already discovered that the gut microbiome is altered in people with chronic heart disease. They subsequently identified compounds that are produced by the diseased microbiome, for instance a bacterial compound called trimethylamine (TMA) that after modification in the liver of the human host causes arteriosclerosis.
February 21, 2022
Scientists Characterize the Imbalanced Gut Bacteria of Patients with Myocardial Infarction, Angina and Heart Failure
February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may…
Read More
Researchers at Gladstone; Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.
February 21, 2022
Getting to the Heart of Complex Disease
February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-…
Read More
Angioscopic findings in the FPA and infrapopliteal lesions
February 21, 2022
Study Finds Ulcerated Plaque in the Femoropopliteal Artery as Source of Arterial Embolism in the Popliteal Arteries
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School…
Read More
An ultrasound is taken of a patient's heart.
February 21, 2022
A Non-invasive Way to Predict Heart Attack and Stroke
February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and…
Read More
Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening heart failure through its randomized controlled trial, Ultrafiltration Versus IV Diuretics in Worsening Heart Failure, the REVERSE-HF Study.
February 21, 2022
Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload
February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now